Literature DB >> 12386559

A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.

I Aprile1, M Muti, M Principi, N Bartolini, A Zenoni, G Tazza, M Italiani, P Ottaviano.   

Abstract

PURPOSE: Perfusion and diffusion Magnetic Resonance Imaging (MRI) studies allow us to quantitatively evaluate the vascularisation and anaplastic grade of glioblastomas based on the regional cerebral blood volume (rCBV) and apparent diffusion coefficient (ADC) values. The aim of our study was to compare these values and enhancement % in order to determine whether enhancement of glioblastomas depends mainly on their vascularisation or anaplastic grade.
MATERIALS AND METHODS: Seventeen patients with brain glioblastomas were studied with perfusion, diffusion and T1-weighted Spin-Echo MR sequences, with and without contrast medium. The quantitative evaluations were made on solid tumour tissue regions of interest (ROI), and the high vascularisation (high rCBV) and low anaplastic grade (high ADC) ROI group was separated from the low vascularisation (low rCBV) and high anaplastic grade (low ADC) group. The mean enhancement % values of the two groups were compared by using statistical METHODS.
RESULTS: In 14 patients there were no statistically significant differences between the two groups. In one patient, the enhancement of high anaplastic grade and low vascularisation ROIs was significantly higher, whereas in two patients, the enhancement of high vascularisation and low anaplastic ROIs clearly prevailed.
CONCLUSIONS: Given that the anaplastic grade is proportional to blood-brain barrier (BBB) impairment, our results show that, in most cases, enhancement of glioblastomas is equally dependent on vascularisation and BBB impairment.

Entities:  

Mesh:

Year:  2002        PMID: 12386559

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  2 in total

1.  Apoptosis imaging for monitoring DR5 antibody accumulation and pharmacodynamics in brain tumors noninvasively.

Authors:  Thomas G Weber; Franz Osl; Anja Renner; Thomas Pöschinger; Stefanie Galbán; Alnawaz Rehemtulla; Werner Scheuer
Journal:  Cancer Res       Date:  2014-02-07       Impact factor: 12.701

2.  Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.

Authors:  A Di Costanzo; S Pollice; F Trojsi; G M Giannatempo; T Popolizio; L Canalis; M Armillotta; A Maggialetti; A Carriero; G Tedeschi; T Scarabino
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.